These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8048078)

  • 21. The effect of tumor necrosis factor binding protein and interleukin-1 receptor antagonist on the development of abdominal aortic aneurysms in a rat model.
    Hingorani A; Ascher E; Scheinman M; Yorkovich W; DePippo P; Ladoulis CT; Salles-Cunha S
    J Vasc Surg; 1998 Sep; 28(3):522-6. PubMed ID: 9737463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on humoral and cell-mediated immunity in Sprague-Dawley rats.
    Fan F; Wierda D; Rozman KK
    Toxicology; 1996 Jan; 106(1-3):221-8. PubMed ID: 8571394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on TNF-alpha levels in the skin of congenic haired and hairless mice.
    Connor MJ; Nanthur J; Puhvel SM
    Toxicol Appl Pharmacol; 1994 Nov; 129(1):12-5. PubMed ID: 7974484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective inhibition of polymorphonuclear neutrophil activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Ackermann MF; Gasiewicz TA; Lamm KR; Germolec DR; Luster MI
    Toxicol Appl Pharmacol; 1989 Dec; 101(3):470-80. PubMed ID: 2557688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice.
    Kitazawa R; Kimble RB; Vannice JL; Kung VT; Pacifici R
    J Clin Invest; 1994 Dec; 94(6):2397-406. PubMed ID: 7989596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces hepatic stellate cell (HSC) activation and liver fibrosis in C57BL6 mouse via activating Akt and NF-κB signaling pathways.
    Han M; Liu X; Liu S; Su G; Fan X; Chen J; Yuan Q; Xu G
    Toxicol Lett; 2017 May; 273():10-19. PubMed ID: 28302560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of cytokines on polymorphonuclear neutrophil infiltration in the mouse. Prostaglandin- and leukotriene-independent induction of infiltration by IL-1 and tumor necrosis factor.
    Sayers TJ; Wiltrout TA; Bull CA; Denn AC; Pilaro AM; Lokesh B
    J Immunol; 1988 Sep; 141(5):1670-7. PubMed ID: 3261759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CYP1A2 is not required for 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced immunosuppression.
    Smialowicz RJ; Burgin DE; Williams WC; Diliberto JJ; Setzer RW; Birnbaum LS
    Toxicology; 2004 Apr; 197(1):15-22. PubMed ID: 15003330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on humoral immunity and lymphocyte subpopulations: differences between mice and rats.
    Smialowicz RJ; Riddle MM; Williams WC; Diliberto JJ
    Toxicol Appl Pharmacol; 1994 Feb; 124(2):248-56. PubMed ID: 8122270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2,3,7,8-Tetrachlorodibenzo-p-dioxin promotes astrocyte activation and the secretion of tumor necrosis factor-α via PKC/SSeCKS-dependent mechanisms.
    Zhang Y; Nie X; Tao T; Qian W; Jiang S; Jiang J; Li A; Guo A; Xu G; Wu Q
    J Neurochem; 2014 Jun; 129(5):839-49. PubMed ID: 24673440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of altered arachidonic acid metabolism in 2,3,7, 8-tetrachlorodibenzo-p-dioxin-induced immune suppression in C57Bl/6 mice.
    Lawrence BP; Kerkvliet NI
    Toxicol Sci; 1998 Mar; 42(1):13-22. PubMed ID: 9538043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of TCDD-induced suppression of antibody production: effect on T cell-derived cytokine production in the primary immune reaction of mice.
    Ito T; Inouye K; Fujimaki H; Tohyama C; Nohara K
    Toxicol Sci; 2002 Nov; 70(1):46-54. PubMed ID: 12388834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relative potency based on hepatic enzyme induction predicts immunosuppressive effects of a mixture of PCDDS/PCDFS and PCBS.
    Smialowicz RJ; DeVito MJ; Williams WC; Birnbaum LS
    Toxicol Appl Pharmacol; 2008 Mar; 227(3):477-84. PubMed ID: 18190939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signaling pathway for 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced TNF-alpha production in differentiated THP-1 human macrophages.
    Cheon H; Woo YS; Lee JY; Kim HS; Kim HJ; Cho S; Won NH; Sohn J
    Exp Mol Med; 2007 Aug; 39(4):524-34. PubMed ID: 17934341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of acute TCDD toxicity by treatment with anti-tumor necrosis factor antibody or dexamethasone.
    Taylor MJ; Lucier GW; Mahler JF; Thompson M; Lockhart AC; Clark GC
    Toxicol Appl Pharmacol; 1992 Nov; 117(1):126-32. PubMed ID: 1440607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-CD40 Treatment of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-exposed C57Bl/6 mice induces activation of antigen presenting cells yet fails to overcome TCDD-induced suppression of allograft immunity.
    Shepherd DM; Steppan LB; Hedstrom OR; Kerkvliet NI
    Toxicol Appl Pharmacol; 2001 Jan; 170(1):10-22. PubMed ID: 11141351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitivity of the SRBC PFC assay versus ELISA for detection of immunosuppression by TCDD and TCDD-like congeners.
    Johnson CW; Williams WC; Copeland CB; DeVito MJ; Smialowicz RJ
    Toxicology; 2000 Dec; 156(1):1-11. PubMed ID: 11162871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period.
    Kimble RB; Matayoshi AB; Vannice JL; Kung VT; Williams C; Pacifici R
    Endocrinology; 1995 Jul; 136(7):3054-61. PubMed ID: 7789332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of tumor necrosis factor and interleukin-1 in endotoxin-induced middle ear effusions.
    Ball SS; Prazma J; Dais CG; Triana RJ; Pillsbury HC
    Ann Otol Rhinol Laryngol; 1997 Aug; 106(8):633-9. PubMed ID: 9270424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.